SCHEMBL12352001

SCHEMBL12352001

NC(=O)c1cc(-c2cccc(F)c2)ccc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.56
TAAR1 Q96RJ0 3/20 0.50
PARP1 P09874 1/20 0.50
ESR2 Q92731 1/20 0.50
CHEK2 O96017 1/20 0.49
IKBKB O14920 1/20 0.49
CDC7 O00311 2/20 0.48
DCLRE1B Q9H816 1/20 0.48
HPGDS O60760 1/20 0.48
ICMT O60725 1/20 0.45
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
ROCK2 O75116 1/20 0.44
PIM1 P11309 1/20 0.44
CDK2 P24941 1/20 0.44
GSK3B P49841 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
DPP4 P27487 1/20 0.44
RORC P51449 1/20 0.43
PTPN1 P18031 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15555830 0.86 IKBKB (0.66) IKBKB
SCHEMBL29363677 0.84 DCLRE1B (0.60) ESR2DCLRE1B
SCHEMBL2160051 0.84 DCLRE1B (0.60) ESR2DCLRE1B
SCHEMBL14783967 0.83 ESR2 (0.50) MAP4K4TAAR1ESR2DCLRE1BCES2
SCHEMBL29537903 0.79 CES2 (0.68) PARP1IKBKBCES2CES1
SCHEMBL366058 0.79 CES2 (0.68) PARP1IKBKBCES2CES1
SCHEMBL29188757 0.79 SLC6A4 (0.49) TAAR1ESR2DCLRE1BGSK3B
SCHEMBL16245147 0.79 DCLRE1B (0.48) MAP4K4TAAR1ESR2DCLRE1BICMT
SCHEMBL15547657 0.79 CHEK2 (0.67) MAP4K4TAAR1PARP1ESR2CHEK2
SCHEMBL27940776 0.79 PARP1 (0.53) MAP4K4TAAR1PARP1ESR2CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094231-A1 THERAPEUTIC AGENTS FOR TREATMENT OF OCULAR HYPERTENSION ALLERGAN, INC. (US) 2011-08-04 WO disclosed